Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Terazosin HCl

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,688Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 AbbVie Inc
    U.S.A
    		 Ilyang Pharmaceutical Co., Ltd. 20060707-48-B-224-08(2) Terazosin hydrochloride 2013-04-11 AbbVie Ireland NL BV Ireland Manorhamilton Road, Sligo, Republic of Ireland
    28/09/2024 ACS DOBFAR SPA
    Italy
    		 Abbott Korea Co., Ltd. 20060707-48-B-224-08 Terazosin hydrochloride hydrate 2006-07-07 AbbVie Ireland NL BV Ireland Manorhamilton Road, Sligo, Republic of Ireland